Submissions
Submission Preparation Checklist
As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.- 1. I declare that all authors had a substantial contribution for this manuscript.
- 2. I declare that all authors approve the final version of the manuscript.
- 3. I declare that the manuscript is not under review of any other journal, and that it has not been published complete or partially in any other journal.
- 4. I declare that the manuscript has not been previously presented.
- 5. I declare that the article is an original contribution, that all the statements presented as facts are resulting from authors’ research, who are responsible for them.
- 6. I declare that the manuscript, complete or in parts, does not infringe any copyright and does not violate any privacy rights.
- 7. I declare that any authors’ conflict of interest regarding statements presented into the manuscript does not exist.
- 8. The authors declare that the procedures were followed according to the regulations established by the Clinical Research and Ethics Committee and to the Helsinki Declaration of the World Medical Association.
- 9. The authors declare having followed the protocols in use at their working center regarding patient’s data publication.
Editorial
Interview
Perspective
Cochrane Corner
Statistics
Study Protocols
A study protocol (“methods paper”) describes in detail the plan for the conduct of a specific clinical study and explains the objective and the role of the study, as well as the way to carry it out. AMP believes that the publication of study protocols will help improve the standards of medical research.
Study protocols will be published without peer review if the study receives ethics committee approval and a grant from an important funding body. Any protocols that do not meet these two criteria will be peer-reviewed.
Protocol articles should report planned or ongoing research studies. If the data collection is concluded, the article will not be considered. We incentivize the submission of protocol articles in an initial phase of the study.
Study protocols must meet the following criteria to be considered for publication
-Articles should pertain to proposed or ongoing research and the dates should be included in the article. Articles that report already completed studies will not be considered.
-Study protocols should have ethics committee approval (if applicable)
- All considerations should respect the following EQUATOR reporting guidelines: PRISMA-P (Preferred Reporting Items for Systematic review and Meta- Analysis Protocols); SPIRIT (Standard Protocol Items for Randomized Trials)
- Registration is compulsory for any clinical trial, as well as for any systematic review and meta-analysis. Approved registrations for clinical trials must meet ICMJE guidance for clinical trials. The number of the clinical trial registration must be included in the abstract.
Words: maximum 2500 words (excluding figures and tables)
Abstract: maximum 300 words
Figures / Tables; maximum 3. Figures should not be composed of more than six images each.
References: maximum 30
Authors: No limit
Short Reports
Preliminary results or new discoveries could give rise to short reports. The text should be organized as introduction, methods, results and discussion.
Words: maximum 1000 words (excluding figures, tables and references).
Abstract: 250 words, no subtitles.
Figures / Tables: maximum 2.
References : maximum 10.
Authors: no limit.
Copyright Notice
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
